Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.
Now here’s the best of what YOU had to say:
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Device firms complain about jobs to keep attention away from great margins, opaque pricing. “During the floor debate, House Republicans used their standard argument against any new tax levy: It will cost jobs. But the heart of their complaint against the device tax, which doesn’t go into effect until January 2013, focused on the undocumented assertion that a slightly higher tax bill for industry would discourage firms from investing in research and development.”
Soda ban is a slippery slope that discourages personal responsibility. “While I want my patients, and indeed everyone, to make wise choices in life, I won’t make them do it. Doctors advise and patients decide. Intelligent folks who know the risks of their choices are entitled to make them freely.”
What healthcare innovations will make a difference? Find out at CONVERGE. “MedCity CONVERGE, MedCityNews.com’s summit on innovation and healthcare convergence July 10 in Philadelphia, brings the entire healthcare ecosystem together for one day of empowering conversations about what’s next in the medical industry. The speaker lineup is almost complete.”
Indiana leads U.S. life sciences jobs and growth. “According to a Battelle/Biotechnology Industry Organization (BIO) Report, “State Bioscience Industry Development 2012,” released today at the BIO International Conference in Boston, Indiana is one of only two states (along with Puerto Rico) that have specialized bioscience employment in four of the five subsectors – Agricultural Feedstock & Chemicals, Drugs & Pharmaceuticals, Medical Devices & Equipment, Research, Testing & Medical Laboratories, and a new subsector, Bioscience Distribution.”
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Preventing fraud: How much do medical practices lose and why? “Medical practices and healthcare organizations are likely losing 5 percent of annual revenues to fraud, waste and abuse, according to the most recent study conducted by the Association of Certified Fraud Examiners.”
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
